Search results :

Enfuvirtide

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: J05AX07

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Erythema 1.2% - 91% x x x x x x x x
Induration 16% - 90% x x x x x x x x
Cyst 0% - 80% x x x x x x x x
Nodule 0% - 80% x x x x x x x x
Ecchymosis 5% - 52% x x x x x x x x
Pruritus 3% - 65% x x x x x x x x
Diarrhoea 26.8% - 33.5% x x x x x x x x
Nausea 20.1% - 23.7% x x x x x x x x
Fatigue 16.1% - 17.4% x x x x x x
Neuropathy peripheral 13.6% - 15.4% x x x x x x x x
Pain 0% - 96% x x x x x x x x
Discomfort 0% - 96% x x x x x x x x
Anxiety 6.8% - 7.5% x x x x x x x x
Influenza 6.2% - 6.5% x x x x
Weight decreased 6.2% - 11.1% x x x x x x x x
Sinusitis 4.9% - 9.5% x x x x x x x x
Skin papilloma 3.1% - 6.6% x x x x
Dry skin 4.3% - 5% x x x
Abdominal pain 3.7% - 4.7% x x x x
Herpes simplex 3.5% - 4.1% x x x x x x x
Lymphadenopathy 1.2% - 5.9% x x x x x x x x
Pain in extremity 2.9% - 3.4% x x x x x
Nasal congestion 2.5% - 3.1% x x x
Gastrooesophageal reflux disease 2.5% - 2.7% x x x
Cough 2.5% - 4.7% x x x x x x x
Folliculitis 2.4% - 2.9% x x x x x
Pancreatitis 2.5% - 3.6% x x x x x x x x
Decreased appetite 2.5% - 8.6% x x x x x x x x
Hypoaesthesia 1.9% - 2.9% x x x
Blood triglycerides increased 1.9% - 2.9% x x x
Irritability 1.9% - 2.3% x x x
Seborrhoeic dermatitis 1.9% - 2.3% x x x
Vertigo 0.6% - 3.6% x x x
Disturbance in attention 1.9% - 2.3% x x x
Haematuria 1.9% - 2.2% x x x
Tremor 1.9% - 2.2% x x x
Hypertriglyceridaemia 1.9% - 2% x x x
Anorexia 1.9% - 3.8% x x x x x x x x
Conjunctivitis 1.9% - 4.1% x x x x x x x x
Dry mouth 1.9% - 2.5% x x x x
Influenza like illness 1.9% - 4.5% x x x x x x x x
Calculus of kidney 1.2% - 2.3% x x x
Nightmare 1.2% - 2.3% x x x
Ear infection 1.2% - 2.2% x x x
Asthenia 0.6% - 2.7% x x x x x x x x
Diabetes mellitus 0.6% - 2% x x x
Acne 0.6% - 2% x x
Myalgia 1.2% - 7% x x x x x x x x
Pneumonia 0.6% - 3.9% x x x x x x x x
Abscess x x x x x x x x
Acquired immunodeficiency syndrome x x
Anaphylactic shock x
Angina unstable x x x x x
Arthralgia x
Back pain x
Pneumonia bacterial x x x x x x
Mental disorder x x x x x x x x
Bone disorder x x x x
Bronchopneumonia x x x x
Oral candidiasis x
Cellulitis x x x x x x x x
Infection x x x x x x x x
Constipation x x x x x x x
Contusion x
Depression x
Dizziness x
Dysgeusia x x x x x x x
Eosinophilia x x x x x x x x
Rash x
Eye disorder x x x x
Body temperature increased x x x x x x x
Gastrointestinal disorder x x x x x x x x
Glomerulonephritis x x x x x x x
Guillain-Barre syndrome x x x x x x
Headache x
Cardiac disorder x x x x x
Blood disorder x x x x x x
Haematoma x
Hepatitis toxic x x x x x
Hyperglycaemia x x x x x x
Hypersensitivity x x x x x x x x
Hypotension x
Immune system disorder x x x x x x
Inflammation x
Mediastinal disorder x x x x x x x x
Cramp muscle x
Nervous system disorder x x x x x x x x
Neuralgia x
Neutropenia x x x x x x
Night sweats x
Opportunistic infection x
Paraesthesia x
Renal failure x x x x x x
Suicide attempt x x x x
Thrombocytopenia x x x x x x
Urinary tract disorder x x x x x x x x
Vomiting x
Chills x
Amylase increased x x x x x
Gamma-glutamyltransferase increased x x x x x
Injection site reaction x x x x x x x x
Injection site pain x x x x x x
Aspartate aminotransferase increased x x x x x
Malnutrition x x x
Unspecified disorder of skin and subcutaneous tissue x x x x x x x
Sickness x x x x
Injection site infection x x x x x x x
Disability x x x x x x x
Abdominal pain upper x x x x x x x
Tenderness x
Throat sore x
Sepsis x x x x x
Hepatobiliary disease x x x x x
VIth nerve paralysis x x x x x x
Rigors x
Respiratory distress x x x x x x
Application site pain x x x x x x
Lipase increased x x x x x
Sweating increased x
Pain nerve x
Infestation NOS x x x x
Blood and lymphatic system disorders x x x x
Ear and labyrinth disorders x x x
Insomnia x x x x x x x
Renal impairment x x x x x x
Renal tubular necrosis x x x x x
Administration site infection x x x x x x x
Immune complex reaction x
Hepatic steatosis x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

enfuvirtide / enfuvirtide

Side effects:62
Source:EMA

Enfuvirtide / FUZEON

Side effects:90
Source:medicines.org.au

enfuvirtide / Fuzeon

Side effects:66
Source:FDA

Enfuvirtide

Side effects:74
Source:FDA Structured Product Label

ENFUVIRTIDE / FUZEON

Side effects:78
Source:FDA

ENFUVIRTIDE / FUZEON

Side effects:79
Source:FDA

ENFUVIRTIDE / FUZEON

Side effects:83
Source:FDA

ENFUVIRTIDE / FUZEON

Side effects:100
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label